Assessment of the Response Profile to Hyaluronic Acid Plus Sorbitol Injection in Patients with Knee Osteoarthritis: Post-Hoc Analysis of a 6-Month Randomized Controlled Trial
In a previous randomized trial, the non-inferiority of two hyaluronic acid injections (Synolis VA versus Synvisc-One) was assessed in patients with knee OA, with a response rate of 79% for Synolis VA. To assess whether a responder profile could be established for this treatment modality, we used the...
| Main Authors: | , , , |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
MDPI AG
2021-10-01
|
| Series: | Biomolecules |
| Subjects: | |
| Online Access: | https://www.mdpi.com/2218-273X/11/10/1498 |
| _version_ | 1797515204672618496 |
|---|---|
| author | Olivier Bruyère Germain Honvo Eduard Vidovic Bernard Cortet |
| author_facet | Olivier Bruyère Germain Honvo Eduard Vidovic Bernard Cortet |
| author_sort | Olivier Bruyère |
| collection | DOAJ |
| description | In a previous randomized trial, the non-inferiority of two hyaluronic acid injections (Synolis VA versus Synvisc-One) was assessed in patients with knee OA, with a response rate of 79% for Synolis VA. To assess whether a responder profile could be established for this treatment modality, we used the Synolis VA arm of a published 6-month prospective, multicenter, comparative, randomized, double-blinded trial. At baseline and during the study, pain and function were assessed using the Western Ontario and McMaster Universities Arthritis Index (WOMAC) questionnaire. Ninety-six subjects from the intention-to-treat trial were included in the analysis. The 6-month change of WOMAC Pain with Synolis VA was not associated with any baseline clinical data. However, the change in WOMAC Function was significantly associated with its baseline level, even after adjustment for potential confounding variables (<i>p</i> = 0.028), i.e., a poorer physical function at baseline was associated with a better response. In conclusion, in addition to the high absolute response rate to Synolis VA, the probability of success is even increased if administered in patients with more limited physical function at baseline. Further research with other potential confounding clinical variables is warranted in order to better applicate the concept of personalized medicine. |
| first_indexed | 2024-03-10T06:42:13Z |
| format | Article |
| id | doaj.art-2fb9e3e0ed994ad2812491390bdb1d53 |
| institution | Directory Open Access Journal |
| issn | 2218-273X |
| language | English |
| last_indexed | 2024-03-10T06:42:13Z |
| publishDate | 2021-10-01 |
| publisher | MDPI AG |
| record_format | Article |
| series | Biomolecules |
| spelling | doaj.art-2fb9e3e0ed994ad2812491390bdb1d532023-11-22T17:34:31ZengMDPI AGBiomolecules2218-273X2021-10-011110149810.3390/biom11101498Assessment of the Response Profile to Hyaluronic Acid Plus Sorbitol Injection in Patients with Knee Osteoarthritis: Post-Hoc Analysis of a 6-Month Randomized Controlled TrialOlivier Bruyère0Germain Honvo1Eduard Vidovic2Bernard Cortet3WHO Collaborating Centre for Public Health Aspects of Musculo-Skeletal Health and Ageing, Division of Public Health, Epidemiology and Health Economics, University of Liège, 4000 Liège, BelgiumWHO Collaborating Centre for Public Health Aspects of Musculo-Skeletal Health and Ageing, Division of Public Health, Epidemiology and Health Economics, University of Liège, 4000 Liège, BelgiumAptissen SA Medical Department, 1228 Plan-les-Ouates, SwitzerlandDepartment of Rheumatology and UR 4490, University Hospital of Lille, 59000 Lille, FranceIn a previous randomized trial, the non-inferiority of two hyaluronic acid injections (Synolis VA versus Synvisc-One) was assessed in patients with knee OA, with a response rate of 79% for Synolis VA. To assess whether a responder profile could be established for this treatment modality, we used the Synolis VA arm of a published 6-month prospective, multicenter, comparative, randomized, double-blinded trial. At baseline and during the study, pain and function were assessed using the Western Ontario and McMaster Universities Arthritis Index (WOMAC) questionnaire. Ninety-six subjects from the intention-to-treat trial were included in the analysis. The 6-month change of WOMAC Pain with Synolis VA was not associated with any baseline clinical data. However, the change in WOMAC Function was significantly associated with its baseline level, even after adjustment for potential confounding variables (<i>p</i> = 0.028), i.e., a poorer physical function at baseline was associated with a better response. In conclusion, in addition to the high absolute response rate to Synolis VA, the probability of success is even increased if administered in patients with more limited physical function at baseline. Further research with other potential confounding clinical variables is warranted in order to better applicate the concept of personalized medicine.https://www.mdpi.com/2218-273X/11/10/1498hyaluronic acidsorbitolinjectionosteoarthritispost-hoc analysis |
| spellingShingle | Olivier Bruyère Germain Honvo Eduard Vidovic Bernard Cortet Assessment of the Response Profile to Hyaluronic Acid Plus Sorbitol Injection in Patients with Knee Osteoarthritis: Post-Hoc Analysis of a 6-Month Randomized Controlled Trial Biomolecules hyaluronic acid sorbitol injection osteoarthritis post-hoc analysis |
| title | Assessment of the Response Profile to Hyaluronic Acid Plus Sorbitol Injection in Patients with Knee Osteoarthritis: Post-Hoc Analysis of a 6-Month Randomized Controlled Trial |
| title_full | Assessment of the Response Profile to Hyaluronic Acid Plus Sorbitol Injection in Patients with Knee Osteoarthritis: Post-Hoc Analysis of a 6-Month Randomized Controlled Trial |
| title_fullStr | Assessment of the Response Profile to Hyaluronic Acid Plus Sorbitol Injection in Patients with Knee Osteoarthritis: Post-Hoc Analysis of a 6-Month Randomized Controlled Trial |
| title_full_unstemmed | Assessment of the Response Profile to Hyaluronic Acid Plus Sorbitol Injection in Patients with Knee Osteoarthritis: Post-Hoc Analysis of a 6-Month Randomized Controlled Trial |
| title_short | Assessment of the Response Profile to Hyaluronic Acid Plus Sorbitol Injection in Patients with Knee Osteoarthritis: Post-Hoc Analysis of a 6-Month Randomized Controlled Trial |
| title_sort | assessment of the response profile to hyaluronic acid plus sorbitol injection in patients with knee osteoarthritis post hoc analysis of a 6 month randomized controlled trial |
| topic | hyaluronic acid sorbitol injection osteoarthritis post-hoc analysis |
| url | https://www.mdpi.com/2218-273X/11/10/1498 |
| work_keys_str_mv | AT olivierbruyere assessmentoftheresponseprofiletohyaluronicacidplussorbitolinjectioninpatientswithkneeosteoarthritisposthocanalysisofa6monthrandomizedcontrolledtrial AT germainhonvo assessmentoftheresponseprofiletohyaluronicacidplussorbitolinjectioninpatientswithkneeosteoarthritisposthocanalysisofa6monthrandomizedcontrolledtrial AT eduardvidovic assessmentoftheresponseprofiletohyaluronicacidplussorbitolinjectioninpatientswithkneeosteoarthritisposthocanalysisofa6monthrandomizedcontrolledtrial AT bernardcortet assessmentoftheresponseprofiletohyaluronicacidplussorbitolinjectioninpatientswithkneeosteoarthritisposthocanalysisofa6monthrandomizedcontrolledtrial |